دورية أكاديمية
أعرض في EDS

Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?

التفاصيل البيبلوغرافية
العنوان: Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
المؤلفون: Bendjelid K; Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: karim.bendjelid@hcuge.ch., Giraud R; Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Von Düring S; Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
المصدر: Anaesthesia, critical care & pain medicine [Anaesth Crit Care Pain Med] 2020 Aug; Vol. 39 (4), pp. 451-452. Date of Electronic Publication: 2020 Jul 09.
نوع المنشور: Editorial; Introductory Journal Article
اللغة: English
بيانات الدورية: Publisher: Published by Elsevier Masson SAS on behalf of the Société française d'anesthésie et de réanimation (Sfar) Country of Publication: France NLM ID: 101652401 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-5568 (Electronic) Linking ISSN: 23525568 NLM ISO Abbreviation: Anaesth Crit Care Pain Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Issy-les-Moulineaux cedex, France : Published by Elsevier Masson SAS on behalf of the Société française d'anesthésie et de réanimation (Sfar), [2015]-
مواضيع طبية MeSH: Betacoronavirus*, Almitrine/*therapeutic use , Coronavirus Infections/*drug therapy , Hypoxia/*drug therapy , Pneumonia, Viral/*drug therapy , Respiratory Distress Syndrome/*drug therapy , Respiratory System Agents/*therapeutic use, Almitrine/administration & dosage ; COVID-19 ; Coronavirus Infections/complications ; Humans ; Hypoxia/etiology ; Pandemics ; Pneumonia, Viral/complications ; Respiratory Distress Syndrome/etiology ; Respiratory System Agents/administration & dosage ; SARS-CoV-2
References: Crit Care. 2020 Jun 16;24(1):353. (PMID: 32546188)
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320. (PMID: 32281885)
Intensive Care Med. 1994 May;20(5):379-89. (PMID: 7930036)
Am J Respir Crit Care Med. 1999 Aug;160(2):473-9. (PMID: 10430716)
Can J Anaesth. 1998 May;45(5 Pt 1):402-9. (PMID: 9598253)
Eur Respir J. 1999 Dec;14(6):1244-5. (PMID: 10624749)
Crit Care Med. 2001 Jan;29(1):32-6. (PMID: 11176154)
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. (PMID: 32505755)
Am J Respir Crit Care Med. 1998 Dec;158(6):1770-7. (PMID: 9847266)
Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. (PMID: 32305591)
Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. (PMID: 32505756)
JAMA. 2020 Jun 9;323(22):2329-2330. (PMID: 32329799)
Crit Care. 2001;5(2):67-71. (PMID: 11299064)
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. (PMID: 32228035)
Chest. 2020 Nov;158(5):2003-2006. (PMID: 32512007)
Anesthesiology. 2015 Apr;122(4):932-46. (PMID: 25587641)
Intensive Care Med. 1997 Sep;23(9):1008. (PMID: 9347377)
فهرسة مساهمة: Keywords: Almitrine; COVID-19; Capillary shunt; Hypoxemia
المشرفين على المادة: 0 (Respiratory System Agents)
9A1222NBG4 (Almitrine)
تواريخ الأحداث: Date Created: 20200713 Date Completed: 20200902 Latest Revision: 20210110
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC7347339
DOI: 10.1016/j.accpm.2020.07.003
PMID: 32653550
قاعدة البيانات: MEDLINE
الوصف
تدمد:2352-5568
DOI:10.1016/j.accpm.2020.07.003